HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): José M. Bernal José M. Revuelta Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernal, J. M. Articles by Revuelta, J. M. Search for Related Content PubMed PubMed Citation Articles by Bernal, J. M. Articles by Revuelta, J. M.

J Thorac Cardiovasc Surg 1998;115:1130-1135
© 1998 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Repair of nonsevere rheumatic aortic valve disease during other valvular procedures: Is it safe?

From the Department of Cardiovascular Surgery, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Spain.

Received for publication April 17, 1997. Revisions requested June 18, 1997; revisions received Dec. 8, 1997. Accepted for publication Dec. 9, 1997. Address for reprints: José M. Bernal, MD, Department of Cardiovascular Surgery, Hospital Universitario Valdecilla, E-39008 Santander, Spain.

Abstract

Objective: To investigate the long-term performance of aortic valve repair, we analyzed the results obtained in a 22-year period in patients who underwent repair of nonsevere rheumatic aortic valve disease during other valvular procedures.
Methods: Fifty-three patients (mean 40 ± 11.6 years of age) with predominant rheumatic mitral valve disease had concomitant aortic valve disease in association with serious tricuspid valve disease in 25 of them. Preoperatively, aortic valve disease was considered moderate in 47.2% of the patients and mild in 52.8%. All patients underwent reparative techniques of the aortic valve (free edge unrolling, 44; subcommissural annuloplasty, 40; commissurotomy, 36) at the time of mitral or mitrotricuspid valve surgery. The completeness of follow-up during the closing interval was 100%, with a mean follow-up of 18.8 years (range 8 to 22.5 years).
Results: Hospital mortality rate was 7.5%. Of 49 surviving patients, 26 (53.1%) died during late follow-up. The actuarial survival curve including hospital mortality was 35.4% ± 8.7% at 22 years. For patients who underwent mitral and aortic valve surgery, the actuarial survival curve at 22 years was 32.3% ± 13%, whereas for patients who had a triple-valve operation the survival was 37.0% ± 10.1% (p = 0.07). Twenty-five patients underwent an aortic prosthetic valve replacement. Actuarial free from aortic structural deterioration and valve-related complications at 22 years was 25.3% ± 9.3% and 12.7% ± 4.8%, respectively.
Conclusions: Long-term functional results of reparative procedures of nonsevere aortic valve disease in patients with predominant rheumatic mitral valve disease have been inadequate at 22 years of follow-up. According to these data, conservative operations for rheumatic aortic valve disease do not seem appropriate.

This article has been cited by other articles:

				J. M. Bernal, A. Ponton, B. Diaz, J. Llorca, I. Garcia, A. Sarralde, C. Diago, and J. M. Revuelta Surgery for rheumatic tricuspid valve disease: a 30-year experience. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 476 - 481. [Abstract] [Full Text] [PDF]

				J. M. Bernal, J. Gutierrez-Morlote, J. Llorca, J. M. San Jose, D. Morales, and J. M. Revuelta Tricuspid Valve Repair: An Old Disease, a Modern Experience Ann. Thorac. Surg., December 1, 2004; 78(6): 2069 - 2074. [Abstract] [Full Text] [PDF]

				N. Bozbuga, V. Erentug, K. Kirali, E. Akinci, O. Isik, and C. Yakut Midterm results of aortic valve repair with the pericardial cusp extension technique in rheumatic valve disease Ann. Thorac. Surg., April 1, 2004; 77(4): 1272 - 1276. [Abstract] [Full Text] [PDF]

				S. Chauvaud, J.-F. Fuzellier, A. Berrebi, A. Deloche, J.-N. Fabiani, and A. Carpentier Long-Term (29 Years) Results of Reconstructive Surgery in Rheumatic Mitral Valve Insufficiency Circulation, September 18, 2001; 104 (2009): I-12 - I-15. [Abstract] [Full Text] [PDF]

				Z. Al Halees, B. Gometza, A. Al Sanei, and C. Duran Repair of moderate aortic valve lesions associated with other pathology: an 11-year follow-up Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 247 - 251. [Abstract] [Full Text] [PDF]

				A. M. Gillinov, E. H. Blackstone, J. White, M. Howard, R. Ahkrass, A. Marullo, and D. M. Cosgrove Durability of combined aortic and mitral valve repair Ann. Thorac. Surg., July 1, 2001; 72(1): 20 - 27. [Abstract] [Full Text] [PDF]

				R. C. Millar, J. M. Arcidi Jr, and P. J.M. Alison The maze III procedure for atrial fibrillation: should the indications be expanded? Ann. Thorac. Surg., November 1, 2000; 70(5): 1580 - 1586. [Abstract] [Full Text] [PDF]

				T. M. Yau, Y. A. F. El-Ghoneimi, S. Armstrong, J. Ivanov, and T. E. David MITRAL VALVE REPAIR AND REPLACEMENT FOR RHEUMATIC DISEASE J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 53 - 61. [Abstract] [Full Text] [PDF]